Polypill access still a challenge

Barriers to the global availability of a polypill remain, despite the growing evidence of its clinical potential and successful adherence rates, experts claim.

An article, published in the latest issue of MJA InSight, examined the difficulties surrounding access to the polypill, including disinterest from drug companies and opposition from certain health professionals, such as cardiologists and public health experts.

Speaking at the World Congress on Cardiology in Melbourne last week, former BMJ editor